Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAXIM® Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19PREV STORYBellerophon Provides Clinical Program Update and Reports Second Quarter 2020 Financial Results